ANTX Stock Data and Insider Activity
ANTX - AN2 Therapeutics, Inc. Common Stock AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
  
     
Chart and Financial Data provided by TradingView
Whale Activity

Recently reported position changes by institutional investors

Senate Trading

Recent trades by U.S. Senators

No data for this ticker
House Trading

Recent trades by U.S. Representatives

No data for this ticker
Insider Trading

Quarterly net insider trading by a company's directors and management

Corporate Flights

Flights by private jets registered to ANTX

No data for this ticker
Government Contracts

Federal grants, loans, and purchases. Click on a date for more info.

Date Agency Amount

2022-09-20 00:00:00

2022-09-20 00:00:00
DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) $4,306,405
WallStreetBets
Number of mentions of ANTX in WallStreetBets Daily Discussion
Date Mentions
1/22/2021 1
3/1/2021 1
U.S. Patents

New patents grants by month

No data for this ticker
Off-Exchange Trading

Yesterday's off-exchange activity

No data for this ticker
Corporate Lobbying

Government lobbying spending instances

No data for this ticker